ocrelizumab
Drug Name | Form | Strength | ARHS | Blue Ridge | Caldwell | Chatham | Johnston | Lenoir | Medical Center | Nash | Pardee | Rex | Rockingham | Southeastern | Wayne | Youth Behavioral Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ocrelizumab (Ocrevus) | SOLUTION, INTRAVENOUS | 30 mg/mL (10 mL) | ||||||||||||||
Ocrelizumab-Hyaluronidase | SOLUTION, SUBCUTANEOUS | 40 mg-1000units/mL (920 mg/23,000 units/23 mL)) |
UNC Health
System Formulary Restriction:
Use of ocrelizumab injection is restricted to outpatient encounters or clinic use only (ie, no inpatient use)
UNC Health IV Compendium Guideline
Med Center
UNC Medical Center Formulary Restrictions